BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 31244287)

  • 1. Over-Expression of Cyclooxygenase-2 in Colorectal Cancer Patients.
    Negi RR; Rana SV; Gupta V; Gupta R; Chadha VD; Prasad KK; Dhawan DK
    Asian Pac J Cancer Prev; 2019 Jun; 20(6):1675-1681. PubMed ID: 31244287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors that contribute to faecal cyclooxygenase-2 mRNA expression in subjects with colorectal cancer.
    Hamaya Y; Yoshida K; Takai T; Ikuma M; Hishida A; Kanaoka S
    Br J Cancer; 2010 Mar; 102(5):916-21. PubMed ID: 20145612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of cyclooxygenase-2 inhibition on serum and tumor gastrins and expression of apoptosis-related proteins in colorectal cancer.
    Konturek PC; Rembiasz K; Burnat G; Konturek SJ; Tusinela M; Bielanski W; Rehfeld J; Karcz D; Hahn E
    Dig Dis Sci; 2006 Apr; 51(4):779-87. PubMed ID: 16615003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased expression of semaphorin 3D is associated with genesis and development in colorectal cancer.
    Wang Z; Ding M; Qian N; Song B; Yu J; Tang J; Wang J
    World J Surg Oncol; 2017 Mar; 15(1):67. PubMed ID: 28320475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlations of IGF-1R and COX-2 Expressions with Ras and BRAF Genetic Mutations, Clinicopathological Features and Prognosis of Colorectal Cancer Patients.
    Jin M; Long ZW; Yang J; Lin X
    Pathol Oncol Res; 2018 Jan; 24(1):45-57. PubMed ID: 28188432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of COX-2 and MMP-13 expressions with gastric cancer and their effects on prognosis.
    Ren J; Liu J; Sui X
    J BUON; 2019; 24(1):187-193. PubMed ID: 30941969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Over-expression of COX-2 mRNA in colorectal cancer.
    Roelofs HM; Te Morsche RH; van Heumen BW; Nagengast FM; Peters WH
    BMC Gastroenterol; 2014 Jan; 14():1. PubMed ID: 24383454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of cyclooxygenase-2 over-expression on the prognosis of colorectal cancer patients. An experience from Western Saudi Arabia.
    Albasri AM; Elkablawy MA; Hussainy AS; Yousif HM; Alhujaily AS
    Saudi Med J; 2018 Aug; 39(8):773-780. PubMed ID: 30106414
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Fredericks E; Dealtry G; Roux S
    Can J Gastroenterol Hepatol; 2018; 2018():4379673. PubMed ID: 30186819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and association of carbonic anhydrase IX and cyclooxygenase-2 in colorectal cancer.
    Tupá V; Drahošová S; Grendár M; Adamkov M
    Pathol Res Pract; 2019 Apr; 215(4):705-711. PubMed ID: 30638861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlated non-nuclear COX2 and low HER2 expression confers a good prognosis in colorectal cancer.
    Zhou FF; Huang R; Jiang J; Zeng XH; Zou SQ
    Saudi J Gastroenterol; 2018; 24(5):301-306. PubMed ID: 29873317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of IGF-1 mRNA isoforms in colorectal carcinoma and normal colon tissue.
    Kasprzak A; Szaflarski W; Szmeja J; Andrzejewska M; Przybyszewska W; Kaczmarek E; Koczorowska M; Kościński T; Zabel M; Drews M
    Int J Oncol; 2013 Jan; 42(1):305-16. PubMed ID: 23165777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interplay between post-translational cyclooxygenase-2 modifications and the metabolic and proteomic profile in a colorectal cancer cohort.
    Prieto P; Jaén RI; Calle D; Gómez-Serrano M; Núñez E; Fernández-Velasco M; Martín-Sanz P; Alonso S; Vázquez J; Cerdán S; Peinado MÁ; Boscá L
    World J Gastroenterol; 2019 Jan; 25(4):433-446. PubMed ID: 30700940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rat colorectal tumours treated with a range of non-steroidal anti-inflammatory drugs show altered cyclooxygenase-2 and cyclooxygenase-1 splice variant mRNA expression levels.
    Vogiagis D; Brown W; Glare EM; O'Brien PE
    Carcinogenesis; 2001 Jun; 22(6):869-74. PubMed ID: 11375891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of adiponectin in early stage of colorectal carcinogenesis.
    Tae CH; Kim SE; Jung SA; Joo YH; Shim KN; Jung HK; Kim TH; Cho MS; Kim KH; Kim JS
    BMC Cancer; 2014 Nov; 14():811. PubMed ID: 25370174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-1260b is a Potential Prognostic Biomarker in Colorectal Cancer.
    Liu DR; Guan QL; Gao MT; Jiang L; Kang HX
    Med Sci Monit; 2016 Jul; 22():2417-23. PubMed ID: 27399918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.
    Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S
    Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer.
    Stanisavljević L; Myklebust MP; Leh S; Dahl O
    Acta Oncol; 2016 Dec; 55(12):1425-1433. PubMed ID: 27435662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression analysis and clinical significance of eIF4E, VEGF-C, E-cadherin and MMP-2 in colorectal adenocarcinoma.
    Gao M; Zhang X; Li D; He P; Tian W; Zeng B
    Oncotarget; 2016 Dec; 7(51):85502-85514. PubMed ID: 27907907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYP24A1 is a potential biomarker for the progression and prognosis of human colorectal cancer.
    Sun H; Wang C; Hao M; Sun R; Wang Y; Liu T; Cong X; Liu Y
    Hum Pathol; 2016 Apr; 50():101-8. PubMed ID: 26997443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.